A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
May 10, 2023
Primary Completion Date
July 16, 2023
Study Completion Date
July 16, 2023
Conditions
Healthy Volunteers
Interventions
DRUG
Brensocatib
Oral tablets.
DRUG
Rifampin
Oral capsules.
DRUG
Esomeprazole
Oral capsules.
Trial Locations (1)
75247
USA001, Dallas
All Listed Sponsors
lead
Insmed Incorporated
INDUSTRY
NCT05826574 - A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants | Biotech Hunter | Biotech Hunter